share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director High Katherine A

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director High Katherine A

CRISPR Therapeutics | 4：持股变动声明-董事 High Katherine A
美股sec公告 ·  05/31 16:21
Moomoo AI 已提取核心信息
Katherine A. High, associated with CRISPR Therapeutics (CRSP.US), was involved in a transaction on 05/30/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding CRISPR Therapeutics stock.
Katherine A. High, associated with CRISPR Therapeutics (CRSP.US), was involved in a transaction on 05/30/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding CRISPR Therapeutics stock.
与CRISPR Therapeutics（CRSP.US）相关的凯瑟琳·海于2024年5月30日参与了一笔交易。公告中未披露交易的具体细节，包括行动类型、状态、所涉股份数量、股票性质、交易价格和交易后的持股情况。建议投资者等待进一步的信息，以充分了解此事件对他们有关CRISPR Therapeutics股票的投资决策的影响。
与CRISPR Therapeutics（CRSP.US）相关的凯瑟琳·海于2024年5月30日参与了一笔交易。公告中未披露交易的具体细节，包括行动类型、状态、所涉股份数量、股票性质、交易价格和交易后的持股情况。建议投资者等待进一步的信息，以充分了解此事件对他们有关CRISPR Therapeutics股票的投资决策的影响。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息